Skip to main content
Languages
English
日本語
中文
ニュース
社会への取り組み
インクルージョン
公益的な法的支援
社会的責任
サステナビリティ
卒業生
オフィス
Open Menu
弁護士等
サービス・産業
インサイト
シドリーについて
採用情報
ニュース
社会への取り組み
インクルージョン
公益的な法的支援
社会的責任
サステナビリティ
卒業生
オフィス
English
日本語
中文
弁護士等
サービス・産業
インサイト
シドリーについて
採用情報
Open Search
Explore Sidley
breadcrumbs
ホーム
インサイト
Resources
Inflation Reduction Act Drug Pricing Resource Center
Sidley Resource
Inflation Reduction Act Drug Pricing Resource Center
Recommended Insights
Inflation Reduction Act: CMS Publishes Final Guidance for Initial Price Applicability Year 2028
October 9, 2025
Global Life Sciences Update
Major U.S. Government Price Reporting Proposals Warrant Industry Comment
July 18, 2025
Global Life Sciences Update
Key Inflation Reduction Act Amendment Broadens U.S. Protection for Orphan Drugs
July 15, 2025
Global Life Sciences Update
CMS Sets Stage for 2028 Medicare Drug Price Negotiations — First Look at Negotiations for Part B
May 21, 2025
Global Life Sciences Update
Drug Pricing Executive Order Aims to End Inflation Reduction Act “Pill Penalty,” Resurrect Policies From First Trump Administration
April 17, 2025
Global Life Sciences Update
Medicare Part D’s New Cost-Smoothing Program: Key Insights and Impacts
September 17, 2024
Healthcare Update
Navigate Investment and Drug Development Under the IRA
January 1, 2024
Global IR @JPMorgan Healthcare Conference
Watch
IRA Considerations for Life Sciences Investors
October 19, 2023
Biotechnology Innovation Organization
Watch
Inflation Reduction Act: CMS Releases New “Medicare Drug Price Negotiation Program” Guidance as Industry Lawsuits Mount
July 14, 2023
Global Life Sciences Update
Impact Of Inflation Reduction Act On Drug Development For U.S. Market
May 23, 2023
GoodLifeSci
HHS Faces IRA Implementation Risk Without Notice and Comment
April 3, 2023
Global Life Sciences Update
Navigating The IRA: What Biopharmas Need To Know
March 30, 2023
Presented by BioCentury and Putnam
Webinar
Inflation Reduction Act: CMS Solicits Comments on Price Negotiation Program Guidance, Makes Part B Coinsurance Announcements
March 20, 2023
Global Life Sciences Update
U.S. Inflation Reduction Act Implementation: Public Opportunities to Comment on New Medicare Inflation Rebates Program
February 17, 2023
Global Life Sciences Update
Inflation Reduction Act Implementation: Serious Hurdles to Accurately Calculating Medicare Part B Inflation Rebates
February 14, 2023
Global Life Sciences Update
Global Life Sciences Update
Inflation Reduction Act: CMS Publishes Final Guidance for Initial Price Applicability Year 2028
October 9, 2025
Global Life Sciences Update
Major U.S. Government Price Reporting Proposals Warrant Industry Comment
July 18, 2025
Global Life Sciences Update
Key Inflation Reduction Act Amendment Broadens U.S. Protection for Orphan Drugs
July 15, 2025
Global Life Sciences Update
CMS Sets Stage for 2028 Medicare Drug Price Negotiations — First Look at Negotiations for Part B
May 21, 2025
Global Life Sciences Update
Drug Pricing Executive Order Aims to End Inflation Reduction Act “Pill Penalty,” Resurrect Policies From First Trump Administration
April 17, 2025
Healthcare Update
Medicare Part D’s New Cost-Smoothing Program: Key Insights and Impacts
September 17, 2024
Watch
Navigate Investment and Drug Development Under the IRA
January 1, 2024
Global IR @JPMorgan Healthcare Conference
Watch
IRA Considerations for Life Sciences Investors
October 19, 2023
Biotechnology Innovation Organization
Global Life Sciences Update
Inflation Reduction Act: CMS Releases New “Medicare Drug Price Negotiation Program” Guidance as Industry Lawsuits Mount
July 14, 2023
GoodLifeSci
Impact Of Inflation Reduction Act On Drug Development For U.S. Market
May 23, 2023
Global Life Sciences Update
HHS Faces IRA Implementation Risk Without Notice and Comment
April 3, 2023
Webinar
Navigating The IRA: What Biopharmas Need To Know
March 30, 2023
Presented by BioCentury and Putnam
Global Life Sciences Update
Inflation Reduction Act: CMS Solicits Comments on Price Negotiation Program Guidance, Makes Part B Coinsurance Announcements
March 20, 2023
Global Life Sciences Update
U.S. Inflation Reduction Act Implementation: Public Opportunities to Comment on New Medicare Inflation Rebates Program
February 17, 2023
Global Life Sciences Update
Inflation Reduction Act Implementation: Serious Hurdles to Accurately Calculating Medicare Part B Inflation Rebates
February 14, 2023
Load More
Contacts
パートナー
Meenakshi Datta
mdatta
@sidley.com
シカゴ
+1 312 853 7169
パートナー
Elizabeth Hardcastle
ehardcastle
@sidley.com
ワシントンD.C.
+1 202 736 8697
パートナー
Donielle McCutcheon
dmccutcheon
@sidley.com
シカゴ
+1 312 853 7282
パートナー
Catherine Y. Starks
cstarks
@sidley.com
シカゴ
+1 312 853 0579
パートナー
Trevor L. Wear
twear
@sidley.com
シカゴ
+1 312 853 7101
Related Capabilities
食品・医薬品・医療機器関連の規制業務
グローバル薬価
ライフサイエンス
ヘルスケア
